Detalhe da pesquisa
1.
Comparative Analysis of a Human Neutralizing mAb Specific for SARS-CoV-2 Spike-RBD with Cilgavimab and Tixagevimab for the Efficacy on the Omicron Variant in Neutralizing and Detection Assays.
Int J Mol Sci
; 24(12)2023 Jun 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37373201
2.
Novel Bi-Specific Immuno-Modulatory Tribodies Potentiate T Cell Activation and Increase Anti-Tumor Efficacy.
Int J Mol Sci
; 23(7)2022 Mar 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-35408827
3.
A Novel Human Neutralizing mAb Recognizes Delta, Gamma and Omicron Variants of SARS-CoV-2 and Can Be Used in Combination with Sotrovimab.
Int J Mol Sci
; 23(10)2022 May 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-35628365
4.
Interactions of Spike-RBD of SARS-CoV-2 and Platelet Factor 4: New Insights in the Etiopathogenesis of Thrombosis.
Int J Mol Sci
; 22(16)2021 Aug 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34445266
5.
Human anti-nucleolin recombinant immunoagent for cancer therapy.
Proc Natl Acad Sci U S A
; 112(30): 9418-23, 2015 Jul 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-26170308
6.
Novel human anti-claudin 1 mAbs inhibit hepatitis C virus infection and may synergize with anti-SRB1 mAb.
J Gen Virol
; 97(1): 82-94, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26519290
7.
WITHDRAWN:A Practical Approach for Management of QT Prolongation Induced by Anticancer Drugs.
Oncologist
; 2016 Mar 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-26975866
8.
Dramatic potentiation of the antiviral activity of HIV antibodies by cholesterol conjugation.
J Biol Chem
; 289(50): 35015-28, 2014 Dec 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-25342747
9.
Effects of a human compact anti-ErbB2 antibody on gastric cancer.
Gastric Cancer
; 17(1): 107-15, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23460348
10.
A Comparison of the Antitumor Efficacy of Novel Multi-Specific Tribodies with Combinations of Approved Immunomodulatory Antibodies.
Cancers (Basel)
; 15(22)2023 Nov 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38001604
11.
Corrigendum: Immune checkpoint inhibitor therapy increases systemic SDF-1, cardiac DAMPs Fibronectin-EDA, S100/Calgranulin, galectine-3, and NLRP3-MyD88-chemokine pathways.
Front Cardiovasc Med
; 10: 1129873, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36742077
12.
Bifidobacterium affects antitumor efficacy of oncolytic adenovirus in a mouse model of melanoma.
iScience
; 26(10): 107668, 2023 Oct 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37720092
13.
Mechanisms of cardiotoxicity associated with ErbB2 inhibitors.
Breast Cancer Res Treat
; 134(2): 595-602, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22674190
14.
Comparison of preclinical cardiotoxic effects of different ErbB2 inhibitors.
Breast Cancer Res Treat
; 133(2): 511-21, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21947749
15.
Evaluation of the quality of life of children with celiac disease and their parents: a case-control study.
Qual Life Res
; 21(1): 77-85, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21598063
16.
Novel tri-specific tribodies induce strong T cell activation and anti-tumor effects in vitro and in vivo.
J Exp Clin Cancer Res
; 41(1): 269, 2022 Sep 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36071464
17.
New Insights on the Role of Anti-PD-L1 and Anti-CTLA-4 mAbs on Different Lymphocytes Subpopulations in TNBC.
Cancers (Basel)
; 14(21)2022 Oct 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-36358708
18.
High-Throughput Monoclonal Antibody Discovery from Phage Libraries: Challenging the Current Preclinical Pipeline to Keep the Pace with the Increasing mAb Demand.
Cancers (Basel)
; 14(5)2022 Mar 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35267633
19.
Oncolytic Adenoviral Vector-Mediated Expression of an Anti-PD-L1-scFv Improves Anti-Tumoral Efficacy in a Melanoma Mouse Model.
Front Oncol
; 12: 902190, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35669438
20.
Immune checkpoint inhibitor therapy increases systemic SDF-1, cardiac DAMPs Fibronectin-EDA, S100/Calgranulin, galectine-3, and NLRP3-MyD88-chemokine pathways.
Front Cardiovasc Med
; 9: 930797, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36158826